In hyperglycemic conditions, PKCβ activation elevates vascular endothelial permeability and inflammation, promoting retinopathy, glomerulosclerosis, and neurovascular complications—effects reversible by PKCβ inhibition [303, 304]. This evidence concerns the gene PRKCB and glomerulosclerosis.